Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

COMPASS Pathways Plc - American Depository Shares (NQ:CMPS)

7.370 +0.320 (+4.54%)
Streaming Delayed Price Updated: 10:37 AM EST, Jan 7, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about COMPASS Pathways Plc - American Depository Shares

< Previous 1 2
...
24 25 26 27 28 29 30 31 Next >
News headline image
Can Psychedelics Actually Cure Depression and PTSD? ↗
There is now data suggesting that magic mushrooms and ecstasy -- combined with talk therapy -- may help people with severe depression and post-traumatic stress disorder. 
Via The Motley Fool
Topics Cannabis
News headline image
Psychedelic Drug Developer Sets Sights On This Age-Old Hallucinogen ↗
MindMed stock fell after it said a Swiss ethics committee cleared it to begin a study on the effects of the hallucinogen mescaline. 
Via Investor's Business Daily
News headline image
Compass Pathways Offers Chance on Exploratory Mental Health Treatments ↗
Over the past year, CMPS stock has been going nowhere fast. However, there's been recent progress in advancing psilocybin-assisted therapy. 
Via InvestorPlace
News headline image
Psyched: MindMed And Compass Q1 Earnings, FDA Approves Therapists Taking MDMA, Wesana Health Goes Public ↗
Two of the most prominent companies in the psychedelics space released their financials for the first quarter of 2021. Compass Pa... 
Via Benzinga
News headline image
Compass Releases Q1 Earnings: Strong Cash Position For Psilocybin R&D Efforts ↗
Compass Pathways (NASDAQ:CMPS), a company researching psyc... 
Via Benzinga
How This Psychedelic Company Could Lead A Turnaround For The Sector ↗
Compass Pathways PLC (NASDAQ:CMPS) is often viewed as the leader in the psychedeli... 
Via Benzinga
News headline image
COMPASS Pathways plc (CMPS) Q1 2021 Earnings Call Transcript ↗
CMPS earnings call for the period ending March 31, 2021. 
Via The Motley Fool
Topics Earnings
Psychedelics Move to The Forefront of Innovative Research as the FDA Approves Large-Scale Testing
Via FinancialNewsMedia
News headline image
Cannabis Countdown: Top 10 Marijuana And Psychedelics Industry News Stories Of The Week ↗
Welcome to the Cannabis Countdo... 
Via Benzinga
Topics Cannabis
News headline image
Why Smaller Psychedelics Companies Should Start Catching Up To The Sector Leaders ↗
Concentration of ownership in psychedelic drug stocks has reached a new extreme. We explain how and why we don't see this trend as being sustainable. 
Via Talk Markets
News headline image
The Next Psychedelic Stock To Uplist On The Nasdaq? ↗
As MindMed Inc makes its long-awaited move to the Nasdaq, the obvious question is: who's next? 
Via Talk Markets
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For May 11, 2021 ↗
Upgrades For CEVA Inc (NASDAQ:CEVA), Barclays upgraded the previous rating of Equal-Weight to Overweight. For the first quarter, CEVA had an EPS of $0.01, compared to year... 
Via Benzinga
News headline image
Cannabis Countdown: Top 10 Marijuana And Psychedelic Stock News Stories Of The Week ↗
Cannabis Countdown: Top 10 Marijuana and Psychedelic Stock News Stories of the Week 
Via Benzinga
Topics Cannabis
Why Companies Are Betting Big On Psychedelic Drugs To Treat Mental Health Epidemic
Via FinancialNewsMedia
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
Gainers Akari Therapeutics (NASDAQ:AKTX) stock moved upwards by 14.1% to $2.67 during Wednesday's pre-market session. The company's market cap stands at $102.7... 
Via Benzinga
News headline image
Second-Chance Buying Opportunity With Psychedelic Stock Warrants ↗
Psychedelic stock warrants delivered epic returns for investors in the big rally in these stocks in 2020. After the pullback in 2021, some of these warrants are again looking attractive. 
Via Talk Markets
News headline image
MindMed Stock Climbs In Nasdaq Debut As Psychedelics Follow Pot's Path To Mainstream ↗
MindMed stock rose in its Nasdaq listing debut on Tuesday, making it the latest psychedelic drug developer to land on a major U.S. exchange. 
Via Investor's Business Daily
Cannabis Countdown: Top 10 Marijuana And Psychedelic Stock News Stories Of The Week ↗
Cannabis Countdown: Top 10 Marijuana and Psychedelic Stock News Stories of the Week 
Via Benzinga
Topics Cannabis
News headline image
Majority Of Pure-Play Psychedelic Drug Stocks Went Up Last Week ↗
41 psychedelic drug stocks trade on the various North American stock exchanges and in the past week 24 went up, 12 went down and 5 had no change in price. 
Via Talk Markets
Psyched: MindMed, Atai Head For Nasdaq, Psychedelics Search Platforms Grow, Champignon Brands Resumes Trading ↗
Two of the most highly funded companies in the psychedelics space announced plans last week to list on the Nasdaq exchange. Months after ... 
Via Benzinga
With Number Of Depression Cases Rising, Psilocybin Medicines Are Being Rapidly Accepted
Via FinancialNewsMedia
News headline image
Déjà Vu: 2021 Slump In Psychedelic Stocks Mirrors 2020 ↗
Charts for most psychedelic drug stocks look terrible in recent weeks. The same was true in the summer of 2020 -- immediately before these stocks exploded higher. Deja vu? 
Via Talk Markets
News headline image
Psychedelic Stocks: Atai Life Sciences IPO Seeks To Raise $100 Million ↗
Atai Life Sciences hopes to raise $100 million in an initial public offering, as other psychedelic stocks seek investor cash. 
Via Investor's Business Daily
Topics Initial Public Offering
Cannabis Countdown: Top 10 Marijuana And Psychedelic Stock News Stories Of The Week, 4/20/2021 ↗
Welcome to the Cannabis... 
Via Benzinga
Topics Cannabis
Psyched: California Psychedelics Bill Passes Second Committee, GH Research Closes $125M Series B, Study Shows Psilocybin Could Equal SSRI Results In Depression ↗
A bill that would remove penalties for the possession, personal use and social sharing of certain natural and synthetic psychedelics in Califo... 
Via Benzinga
News headline image
Pure-Play Psychedelic Drug Stocks Index Declined 5.7% This Week ↗
In the past week, of the 41 psychedelic drug stocks that trade on the various North American stock exchanges only nine went up, in price while 31 went down and one had no change. 
Via Talk Markets
News headline image
The Daily Biotech Pulse: Merck Shelves 2 COVID-19 Studies, Bristol-Myers Squibb Gets European Regulatory Nod, InspireMD's Reverse Split ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 14) 10x Genomics, Inc. (NASDAQ... 
Via Benzinga
Cannabis Countdown: Top 10 Marijuana And Psychedelic Stock News Stories Of The Week ↗
Welcome to the Cannabis... 
Via Benzinga
Topics Cannabis
Biotech Companies Driving Psychedelics Industry Forward with Key Research
Via FinancialNewsMedia
News headline image
Psychedelic Stocks Primed For Atai-MindMed Bounce ↗
It's now looking like the atai Life Sciences IPO and the MindMed uplisting to the Nasdaq could occur within weeks of each other. We point out what that means for investors in psychedelic stocks. 
Via Talk Markets
Topics Initial Public Offering
< Previous 1 2
...
24 25 26 27 28 29 30 31 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.